This campaign is not currently active. Please contact info@hpcimedia.com with any questions you may have.
Many anti-reflux medications on the market are available in the form of suspensions containing sodium alginate as the active ingredient. Corresponding tablet formulations are still less common, despite their greater convenience and stability.
The study aimed to develop a chewable anti-reflux tablet by direct compression. A formulation composed of VIVAPHARM® Sodium Alginate PH R5, and the excipients PROSOLV® SMCC 50, EMDEX® and PRUV® was developed, leading to an effective solid dosage form to prevent reflux.
Terms & Conditions | Privacy Policy | Contact us at info@hpcimedia.com
© HPCi Media Limited | Registered in England No. 6716035 | Natraj Building The Tanneries, 55 Bermondsey St, London SE1 3XG | VAT GB 939828072